|
|
| Find Services | News & Information | Rules & Regulations | Business Information |
Browse by Funding Source Search Results:
2 item(s)
| Title: | Shared Neurobiology of Fragile X Syndrome and Autism (R03): PA-06-429 |
|---|---|
| Source: | National Institute of Mental Health/National Institute of Neurological Disorders and Stroke/National Institute of Child Health and Human Development/Institute of Neurosciences, Mental Health and Addiction/Institute of Genetics |
| Subject(s): | mental health/medical research |
| Deadline: | 2/1, 6/1, 10/1. |
| $Available: | Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. |
| Eligibility: | For-profit and nonprofit organizations; public or private institutions, such as universities, colleges, hospitals and laboratories; Units of state and local government; eligible institutions of the federal government; domestic and foreign institutions; faith-based or community-based organizations; Indian/Native American tribal government (federally recognized and other than federally recognized); and Indian/Native American tribally designated organization. |
| Purpose: | This announcement solicits NIH Small Research Grant (R03) applications for the support of research, which is aimed at characterizing, understanding and treating etiological and pathophysiological mechanisms common to both Fragile X syndrome (FXS) and autism (including autism spectrum disorders such as Rett syndrome). |
| CFDA: | 93.242, 93.853, 93.865 |
| Contact: | Thomas Lehner, (301) 443-1706, fax: (301) 443-4740, e-mail: tlehner@mail.nih.gov |
| URL: | http://grants.nih.gov/grants/guide/pa-files/PA-06-429.html |
| Alert#: | 17.05.05 |
| From: | Grants.gov e-mail, 5/25/06 |
[
Back to Top ]
| Title: | Shared Neurobiology of Fragile X Syndrome and Autism (R01): PA-07-284 |
|---|---|
| Source: | National Institute of Mental Health/National Institute of Neurological Disorders and Stroke/National Institute of Child Health and Human Development/Institute of Neurosciences, Mental Health and Addiction/Institute of Genetics |
| Subject(s): | mental health/medical research/disabilities |
| Deadline: | 2/5, 6/5, 10/5. Expires 7/2/08. |
| $Available: | Awards issued under this announcement are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. |
| Eligibility: | Public/state/private controlled institutions of higher education, nonprofits with and without 501(c)(3) IRS status (other than institutions of higher education), small businesses, for-profit organizations (other than small businesses), state governments, U.S. territories or possessions, Indian/Native American tribal government (federally recognized and other than federally recognized), Indian/Native American tribally designated organizations, non-domestic (non-U.S.) entities, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Alaska native and native Hawaiian serving institutions, regional organizations, eligible agencies of the federal government, and faith-based or community-based organizations. |
| Purpose: | The National Institute of Mental Health (NIMH), National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Child Health and Human Development (NICHD) have entered into a public-private partnership with the Canadian Institutes of Health Research (CIHR), the Health Research Board, Ireland (HRB), Cure Autism Now (CAN), the National Alliance for Autism Research (NAAR), Autism Speaks and the FRAXA Research Foundation (FRAXA) to jointly sponsor this Funding Opportunity Announcement (FOA), which is aimed at characterizing, understanding and treating etiological and pathophysiological mechanisms common to both Fragile X syndrome (FXS) and autism (including autism spectrum disorders such as Rett syndrome). |
| CFDA: | 93.853, 93.242, 93.865 |
| Contact: | Thomas Lehner, (301) 443-1706, fax: (301) 402-4740, e-mail: tlehner@mail.nih.gov |
| URL: | http://grants.nih.gov/grants/guide/pa-files/PA-07-284.html |
| Alert#: | 18.01.03 |
| From: | Grants.gov e-mail, 1/10/07 |
[
Back to Top ]
Last updated May 24, 2005
| Contact Us | Compact with Texans | File Viewing Information | Homeland Security | Internet Policy | Site Map | Statewide Search | Texas Online |